| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.411 | 36.486 | 42.213 | 41.877 | 41.840 | 41.986 | 41.870 | 41.914 | 52.641 | 52.463 |
| Total Income - EUR | 54.748 | 81.083 | 46.985 | 57.517 | 45.201 | 45.572 | 43.008 | 41.967 | 58.311 | 55.806 |
| Total Expenses - EUR | 34.034 | 53.125 | 24.751 | 23.547 | 19.760 | 20.157 | 12.230 | 2.188 | 12.652 | 5.009 |
| Gross Profit/Loss - EUR | 20.715 | 27.958 | 22.234 | 33.970 | 25.442 | 25.415 | 30.777 | 39.778 | 45.659 | 50.797 |
| Net Profit/Loss - EUR | 19.622 | 26.863 | 20.967 | 32.714 | 24.186 | 24.281 | 29.660 | 38.658 | 38.719 | 43.808 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mathiesen Lars Agro Societate În Nume Colectiv
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 566.029 | 560.256 | 550.775 | 540.668 | 530.197 | 520.146 | 508.611 | 510.189 | 508.642 | 505.799 |
| Current Assets | 61.564 | 12.614 | 45.804 | 75.133 | 41.863 | 39.909 | 5.597 | 44.583 | 63.102 | 8.761 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.042 | 2.125 | 2.052 | 0 | 30 | 827 | 329 | 496 | 58 | 1.566 |
| Cash | 60.522 | 10.489 | 43.751 | 75.133 | 41.833 | 39.082 | 5.267 | 44.087 | 63.044 | 7.195 |
| Shareholders Funds | 1.462 | 28.310 | 48.798 | 80.616 | 103.241 | 125.566 | 152.441 | 191.571 | 229.709 | 272.233 |
| Social Capital | 1.184 | 1.172 | 1.153 | 1.131 | 1.109 | 1.088 | 1.064 | 1.068 | 1.064 | 1.058 |
| Debts | 626.131 | 544.560 | 547.781 | 535.184 | 468.819 | 434.489 | 361.767 | 363.201 | 342.035 | 242.327 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4110 - 4110" | |||||||||
| CAEN Financial Year |
4110
|
|||||||||
Comments - Mathiesen Lars Agro Societate În Nume Colectiv